Le ROCE de Lepidico Limited est 0.00%
Le retour sur capital utilisé (ROCE) est un ratio financier qui mesure la rentabilité d'une entreprise et l'efficacité avec laquelle son capital est utilisé.
Return on capital employed (ROCE) is the total amount of capital that a company has utilized in order to generate profits. It is the sum of shareholders' equity and debt liabilities. It can be simplified as total assets minus current liabilities.
ROCE is especially useful when comparing the performance of companies in capital-intensive sectors. ROCE considers debt and other liabilities as well compared to other fundamentals which only analyze profitability related to a company’s common equity. This provides a better indication of financial performance for companies with significant debt. For a company, the ROCE trend over the years is also an important indicator of performance. In general, investors tend to favor companies with stable and rising ROCE numbers over companies where ROCE is volatile and bounces around from one year to the next.
Instead of using capital employed at an arbitrary point in time, analysts and investors often calculate ROCE based on the average capital employed (ROACE), which takes the average of opening and closing capital employed for the time period.
Lepidico Limited engages in the exploration, development, and production of lithium chemicals in Australia and internationally. The company operates through two segments, Mineral Exploration and Technology. Its technologies include L-Max technology, a hydro-metallurgical process for processing lithium mica slurry; S-Max that produces amorphous silica from a range of mica minerals, including lithium micas; and LOH-Max process, which produces high purity lithium hydroxide from lithium sulphate. In addition, it holds an 80% interest in the Karibib project located within the Karibib pegmatite belt in central Namibia in southwestern Africa. Lepidico Limited has a strategic collaboration with Cornish Lithium Ltd to focus on the development of a lithium chemical manufacturing center. The company was incorporated in 1979 and is based in Belmont, Australia.